Agency Forms Undergoing Paperwork Reduction Act Review, 5667-5668 [2020-01860]
Download as PDF
<![CDATA[
5667
Federal Register / Vol. 85, No. 21 / Friday, January 31, 2020 / Notices
diagnosed at late stages, leading to low
five-year survival rates. While previous
studies are able to identify some of the
needs of ovarian cancer survivors,
particularly related to physical
complications and side effects,
additional research is needed to further
understand the experiences and needs
of survivors.
The National Academies of Sciences,
Engineering, and Medicine released
their report, Ovarian Cancers: Evolving
Paradigms in Research and Care, which
identified key priorities for researchers,
including recommending research on
the ‘‘supportive care needs of ovarian
cancer survivors throughout the disease
trajectory’’. In order to address these
research gaps and supplement current
knowledge of the ongoing needs of
survivors, including how to implement
programs and interventions to improve
their health, CDC has supported a
survey of ovarian cancer survivors.
The goal of this project is to better
understand the needs of ovarian cancer
survivors and how to more effectively
develop interventions targeted to this
population. To achieve this goal,
multiple recruitment methods will be
utilized to recruit this unique
population of women for the study. By
using state cancer registries, social
media advertisements, and respondentdriven sampling (RDS), the study will
ensure recruitment of a diverse
population of women.
This study will focus on the following
research questions:
1. What physical and mental
conditions do ovarian cancer survivors
experience?
2. What kinds of pharmacologic and
non-pharmacologic interventions do
ovarian cancer survivors utilize to
manage their conditions?
3. What barriers to ovarian cancer
survivors have in accessing and
receiving appropriate diagnostic care,
treatment, and follow-up care?
4. What unmet needs do ovarian
cancer survivors have?
The overall sample design targets
1,500 completed interviews. We assume
that approximately 80% of completed
surveys will come from more traditional
sampling utilizing lists from the state
cancer registries (n=1,200). The
remainder of the completed interviews
will come through social media
outreach and respondent-driven
sampling (RDS) methods (n=300).
For the social media recruitment,
individuals will be recruited to
participate in the web survey through
advertisements posted on social media
sites. These ads are targeted toward the
specific population of women we wish
to complete the survey. Interested
respondents who click on an ad will be
routed to the survey landing page which
will explain the purpose of the study
and include consent language. If the
respondent is eligible, she will complete
the same survey as those recruited via
the state cancer registries.
Each recruitment method (registrybased or social media-based) will have
an opportunity to recruit other women
into the study through respondentdriven sampling (RDS). We anticipate
that the majority of completed
interviews will be obtained through
traditional sampling practices, RDS
provides an efficient way to identify
other potentially eligible respondents
through a networked-based recruitment
approach.
Participation is voluntary. There are
no costs to respondents other than their
time. The total estimated annual burden
hours are 1,253.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden per
response
(in hours)
Form name
Ovarian cancer survivors—state cancer registries.
Ovarian cancer survivors—social media recruitment.
Ovarian cancer survivors—Respondent Driven Sampling.
Ovarian cancer survivors recruited via social
medial and RDS (ineligible).
Mail-in or web-based questionnaire ...............
1,200
1
50/60
Web-based Questionnaire .............................
195
1
50/60
Web-based Questionnaire .............................
105
1
50/60
Web-based Screener Only .............................
100
1
2/60
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–01855 Filed 1–30–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
jbell on DSKJLSW7X2PROD with NOTICES
Number of
respondents
Type of respondents
[30Day–20–1163]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
VerDate Sep<11>2014
17:16 Jan 30, 2020
Jkt 250001
has submitted the information
collection request titled CDC Fellowship
Programs Assessments for data
collections associated with quality
improvement of CDC fellowship
programs to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on
September 25, 2019 to obtain comments
from the public and affected agencies.
CDC received two non-substantive
comments related to the previous
notice. This notice serves to allow an
additional 30 days for public and
affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
E:\FR\FM\31JAN1.SGM
31JAN1
5668
Federal Register / Vol. 85, No. 21 / Friday, January 31, 2020 / Notices
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Data Collection for CDC Fellowship
Programs (OMB Control No. 0920–1163,
Exp. 2/29/2020)—Extension—Division
of Scientific Education and Professional
Development (DSEPD), Center for
Surveillance, Epidemiology, and
Laboratory Services (CSELS), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC’s mission is to protect America
from health, safety, and security threats,
both foreign and in the U.S. To ensure
a competent, sustainable, and
empowered public health workforce
prepared to meet these challenges, CDC
plays a key role in developing,
implementing, and managing a number
of fellowship programs. A fellowship is
defined as a training or work experience
lasting at least one month and
consisting of primarily experiential (i.e.,
on-the-job) learning, in which the
trainee has a designated mentor or
supervisor. CDC fellowships are
intended to develop public health
professionals, enhance the public health
workforce, and strengthen
collaborations with partners in public
health and healthcare organizations,
academia, and other stakeholders in
governmental and non-governmental
organizations. Assessing fellowship
activities is essential to ensure that the
public health workforce is equipped to
promote and protect the public’s health.
CDC requests a three-year extension of
a generic clearance to collect data about
its fellowship programs, as they relate to
public health workforce development.
Data collections will allow for ongoing,
collaborative, and actionable
communications between CDC
fellowship programs and stakeholders
(e.g., fellows, supervisors/mentors,
alumni). These collections might
include short surveys, interviews, and
focus groups. Intended use of the
resulting information is to
• inform planning, implementation,
and continuous quality improvement of
fellowship activities and services;
• improve efficiencies in the delivery
of fellowship activities and services;
and
• determine to what extent fellowship
activities and services are achieving
established goals.
Collection and use of information
about CDC fellowship activities will
help ensure effective, efficient, and
satisfying experiences among fellowship
program participants and stakeholders.
CDC estimates that annually, a given
fellowship program will conduct one
query each with one of the three
respondent groups: Fellowship
applicants or fellows; mentors,
supervisors, or employers; and alumni.
The total annualized burden hours of
2,957 was determined as depicted in the
following table.
OMB approval is requested for three
years. There are no costs to respondents
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Applicants or fellows .......................................
Mentors, supervisors, or employers ...............
Alumni .............................................................
Fellowship Data Collection Instrument ...........
Fellowship Data Collection Instrument ...........
Fellowship Data Collection Instrument ...........
Jeffery M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–01860 Filed 1–30–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–D–0307]
jbell on DSKJLSW7X2PROD with NOTICES
Number of
respondents
Type of respondents
Recommendations To Reduce the
Possible Risk of Transmission of
Creutzfeldt-Jakob Disease and Variant
Creutzfeldt Jakob Disease by Blood
and Blood Components; Draft
Guidance for Industry; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
VerDate Sep<11>2014
17:16 Jan 30, 2020
Jkt 250001
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a draft
guidance entitled ‘‘Recommendations to
Reduce the Possible Risk of
Transmission of Creutzfeldt-Jakob
Disease and Variant Creutzfeldt Jakob
Disease by Blood and Blood
Components.’’ The draft guidance
provides blood establishments that
collect blood and blood components
with revised recommendations intended
to reduce the possible risk of
transmission of Creutzfeldt-Jakob
disease (CJD) and variant CreutzfeldtJakob disease (vCJD) by blood and blood
components. The recommendations in
the draft guidance apply to the
collection of Whole Blood and blood
components intended for transfusion or
for use in further manufacturing,
including Source Plasma. The draft
guidance replaces the document entitled
‘‘Amendment to ‘Revised Preventive
SUMMARY:
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
1,848
370
3,696
Number of
responses per
respondent
1
1
1
Average
burden per
response
(in hours)
30/60
30/60
30/60
Measures to Reduce the Possible Risk of
Transmission of Creutzfeldt-Jakob
Disease and Variant Creutzfeldt-Jakob
Disease by Blood and Blood Products,’ ’’
Draft Guidance for Industry, dated
December 2017, and when finalized,
will supersede the document entitled
‘‘Revised Preventive Measures to
Reduce the Possible Risk of
Transmission of Creutzfeldt-Jakob
Disease and Variant Creutzfeldt-Jakob
Disease by Blood and Blood Products,
Guidance for Industry,’’ dated May 2010
and updated January 2016.
Submit either electronic or
written comments on the draft guidance
by March 31, 2020 to ensure that the
Agency considers your comment on this
draft guidance before it begins work on
the final version of the guidance.
DATES:
You may submit comments
on any guidance at any time as follows:
ADDRESSES:
E:\FR\FM\31JAN1.SGM
31JAN1
]]>Agencies
[Federal Register Volume 85, Number 21 (Friday, January 31, 2020)]
[Notices]
[Pages 5667-5668]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01860]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-20-1163]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled CDC Fellowship Programs Assessments for data
collections associated with quality improvement of CDC fellowship
programs to the Office of Management and Budget (OMB) for review and
approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on September
25, 2019 to obtain comments from the public and affected agencies. CDC
received two non-substantive comments related to the previous notice.
This notice serves to allow an additional 30 days for public and
affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other
[[Page 5668]]
technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Data Collection for CDC Fellowship Programs (OMB Control No. 0920-
1163, Exp. 2/29/2020)--Extension--Division of Scientific Education and
Professional Development (DSEPD), Center for Surveillance,
Epidemiology, and Laboratory Services (CSELS), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
CDC's mission is to protect America from health, safety, and
security threats, both foreign and in the U.S. To ensure a competent,
sustainable, and empowered public health workforce prepared to meet
these challenges, CDC plays a key role in developing, implementing, and
managing a number of fellowship programs. A fellowship is defined as a
training or work experience lasting at least one month and consisting
of primarily experiential (i.e., on-the-job) learning, in which the
trainee has a designated mentor or supervisor. CDC fellowships are
intended to develop public health professionals, enhance the public
health workforce, and strengthen collaborations with partners in public
health and healthcare organizations, academia, and other stakeholders
in governmental and non-governmental organizations. Assessing
fellowship activities is essential to ensure that the public health
workforce is equipped to promote and protect the public's health.
CDC requests a three-year extension of a generic clearance to
collect data about its fellowship programs, as they relate to public
health workforce development. Data collections will allow for ongoing,
collaborative, and actionable communications between CDC fellowship
programs and stakeholders (e.g., fellows, supervisors/mentors, alumni).
These collections might include short surveys, interviews, and focus
groups. Intended use of the resulting information is to
inform planning, implementation, and continuous quality
improvement of fellowship activities and services;
improve efficiencies in the delivery of fellowship
activities and services; and
determine to what extent fellowship activities and
services are achieving established goals.
Collection and use of information about CDC fellowship activities
will help ensure effective, efficient, and satisfying experiences among
fellowship program participants and stakeholders.
CDC estimates that annually, a given fellowship program will
conduct one query each with one of the three respondent groups:
Fellowship applicants or fellows; mentors, supervisors, or employers;
and alumni. The total annualized burden hours of 2,957 was determined
as depicted in the following table.
OMB approval is requested for three years. There are no costs to
respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Applicants or fellows................. Fellowship Data 1,848 1 30/60
Collection Instrument.
Mentors, supervisors, or employers.... Fellowship Data 370 1 30/60
Collection Instrument.
Alumni................................ Fellowship Data 3,696 1 30/60
Collection Instrument.
----------------------------------------------------------------------------------------------------------------
Jeffery M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-01860 Filed 1-30-20; 8:45 am]
BILLING CODE 4163-18-P
